I. Ferry

Picosecond Infrared Laser Desorption Mass Spectrometry Identifies Medulloblastoma Subgroups on Intrasurgical Timescales.

A. Zarrine-Afsar, J. Rutka, D. Munoz, 2019, Cancer research.

Mass Spectrometry Imaging Reveals a Gradient of Cancer-like Metabolic States in the Vicinity of Cancer Not Seen in Morphometric Margins from Microscopy.

A. Zarrine-Afsar, J. Rutka, C. McIntosh, 2021, Analytical chemistry.

Familial Syndromes

S. Alli, Isabelle Ferry, James T. Rutka, 2020, Textbook of Pediatric Neurosurgery.

In situ tissue pathology from spatially encoded mass spectrometry classifiers visualized in real time through augmented reality†

A. Zarrine-Afsar, R. Weersink, J. Rutka, 2020, Chemical science.

Feasibility of Busulfan Melphalan and Stem Cell Rescue After 131I-MIBG and Topotecan Therapy for Refractory or Relapsed Metastatic Neuroblastoma: The French Experience

G. Schleiermacher, J. Michon, D. Valteau‐Couanet, 2018, Journal of pediatric hematology/oncology.

Rapid determination of medulloblastoma subgroup affiliation with mass spectrometry using a handheld picosecond infrared laser desorption probe† †Electronic supplementary information (ESI) available. See DOI: 10.1039/c7sc01974b Click here for additional data file.

A. Zarrine-Afsar, J. Rutka, Michael D. Taylor, 2017, Chemical science.

[The art of war as applied to pediatric gliomas: Know your enemy].

A. Furlan, S. Meignan, P. Leblond, 2021, Medecine sciences : M/S.